Theriogenology
Volume 69, Issue 9 , Pages 1159-1164 , June 2008

Conventional pluripotency markers are unspecific for bovine embryonic-derived cell-lines

Received 16 October 2007 ,Revised 15 February 2008 ,Accepted 16 February 2008.

References 

  1. Gins I, Luo Y, Miura T, Thies S, Branderberger R, Gerecht-Nir S, et al. Differences between human and mouse embryonic stem cells. Dev Biol. 2004;269:360–380
  2. Keefer CL, Pant D, Blomberg L, Talbot NC. Challenges and prospects for the establishment of embryonic stem cell lines of domestic ungulates. Anim Reprod Sci. 2007;98:147–168
  3. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells. 2002;20:329–337
  4. Gjørret JO, Maddox-Hyttel P. Attempts towards derivation and establishment of bovine embryonic stem cell-like cultures. Rep Fert Dev. 2005;17:113–124
  5. Mitalipova M, Beyhan Z, First N. Pluripotency of bovine embryonic cell line derived from precompacting embryos. Cloning. 2001;3:59–67
  6. Saito S, Sawai K, Ugai H, Moriyasu S, Minamihashi A, Yamammoto Y, et al. Generation of cloned calves and transgenic chimeric embryos from bovine embryonic stem-like cells. Biochem Biophys Res Commun. 2003;309:104–113
  7. Wang L, Duan E, Sung L, Jeong B, Yang X, Tian C. Generation and characterization of pluripotent stem cells from cloned bovine embryos. Biol Reprod. 2005;73:149–155
  8. Degrelle SA, Campion E, Cabau C, Piumi F, Reinaud P, Richard C, et al. Molecular evidence for a critical period in mural trophoblast development in bovine blastocysts. Dev Biol. 2005;288(2):448–460
  9. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643–655
  10. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113:631–642
  11. Adjaye J, Huntress J, Herwig R, BenKahla A, Brink TC, Wierling C, et al. Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells. 2005;23(10):1514–1525
  12. Gauffman G, Van de Velde H, Liebaers I, Steirteghem A. Oct-4 mRNA and protein expression during human preimplantation development. Mol Hum Reprod. 2005;11(3):173–181
  13. Kirchhof N, Carnwath JW, Lemme E, Anastassiadis K, Schöle H, Niemann H. Expression pattern of Oct-4 in preimplantation embryos of different species. Biol Reprod. 2000;63:1698–1705
  14. Vejlsted M, Avery B, Schmidt M, Greeve T, Alexopoulus N, Maddoz-Hyttel P. Ultrastructural and immunohistochemical characterization of the bovine epiblast. Biol Reprod. 2005;72(3):678–686
  15. Stice SL, Strelchenko N, Keefer CL, Matthews L. Pluripotent bovine embryonic cell lines diret embryonic development following nuclear transfer. Biol Reprod. 1996;54:100–110
  16. Vejlsted M, Avery B, Gjorret JO, Maddoz-Hyttel P. Effect of leukaemia inhibitory factor (LIF) on in vitro produced bovine embryos and their outgrowth colonies. Mol Reprod Dev. 2005;70(4):445–454
  17. Rodríguez A, de Frutos C, Díez C, Caamaño JN, Facal N, Duque P, et al. Effects of human versus mouse leukemia inhibitory factor on the in vitro development of bovine embryos. Theriogenology. 2007;67(5):1092–1095
  18. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).. Proc Natl Acad Sci USA. 1978;75:5565–5569
  19. Boiani M, Schöler HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005;6(11):872–884
  20. Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans MJ. Satge-specific embryonic antigen involves α1→3 fucosylated type 2 blood group chains. Nature. 1981;292:156–158
  21. Shevinsky LH, Knowles BB, Damjanov I, Solter D. Monoclonal antibody to murine embryos dfines a stag-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell. 1982;30:697–705
  22. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, et al. Pluripotency embryona carcinoma clones derived from human teratocarcinoma cell line Tera-2: differentiation in vivo and in vitro. Lab Invest. 1984;50:147–162
  23. Fenderson BA, Andrews PW, Nudelman E, Clausen H, Hakamori S. Glycolipid core structure switching from globo- to lacto- and gangli-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol. 1987;122:21–34
  24. Hyslop L, Stojkovic M, Amstrong L, Walter T, Stojkovic P, Przyborski S, et al. Down regulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells. 2005;23(8):1035–1043
  25. Hough SR, Clements I, Welch PJ, Wiederholt KA. Differentation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells. 2006;24(6):1467–1475
  26. He S, Pant D, Schiffmarcher A, Bischoff S, Melican D, Gavin W, et al. Developmental expression of pluripotency determining factors in caprine embryos: novel pattern of NANOG protein localization in the nucleolus. Mol Reprod Dev. 2006;73(12):1512–1522
  27. Rossant J. Stem cells and lineage development in the mammalian blastocyst. Reprod Fert Dev. 2007;19:111–118

PII: S0093-691X(08)00101-5

doi: 10.1016/j.theriogenology.2008.02.014

Theriogenology
Volume 69, Issue 9 , Pages 1159-1164 , June 2008

Article Tools

* Image Usage & Resolution